FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2187788467> ?p ?o ?g. }

• W2187788467 abstract "The effectiveness of lipid-lowering medication critically depends on the patients' compliance and the efficacy of the prescribed drug.The primary objective of this multicentre study was to compare the efficacy of rosuvastatin with or without access to compliance initiatives, in bringing patients to the Joint European Task Force's (1998) recommended low-density lipoprotein cholesterol (LDL-C) level goal (LDL-C, <3.0 mmol/L) at week 24. Secondary objectives were comparison of the number and percentage of patients achieving European goals (1998, 2003) for LDL-C and other lipid parameters.Patients with primary hypercholesterolaemia and a 10-year coronary heart disease risk of >20% received open label rosuvastatin treatment for 24 weeks with or without access to compliance enhancement tools. The initial daily dosage of 10 mg could be doubled at week 12. Compliance tools included: a) a starter pack for subjects containing a videotape, an educational leaflet, a passport/goal diary and details of the helpline and/or website; b) regular personalised letters to provide message reinforcement; c) a toll-free helpline and a website.The majority of patients (67%) achieved the 1998 European goal for LDL-C at week 24. 31% required an increase in dosage of rosuvastatin to 20 mg at week 12. Compliance enhancement tools did not increase the number of patients achieving either the 1998 or the 2003 European target for plasma lipids. Rosuvastatin was well tolerated during this study. The safety profile was comparable with other drugs of the same class. 63 patients in the 10 mg group and 58 in the 10 mg Plus group discontinued treatment. The main reasons for discontinuation were adverse events (39 patients in the 10 mg group; 35 patients in the 10 mg Plus group) and loss to follow-up (13 patients in the 10 mg group; 9 patients in the 10 mg Plus group). The two most frequently reported adverse events were myalgia (34 patients, 3% respectively) and back pain (23 patients, 2% respectively). The overall rate of temporary or permanent study discontinuation due to adverse events was 9% (n = 101) in patients receiving 10 mg rosuvastatin and 3% (n = 9) in patients titrated up to 20 mg rosuvastatin.Rosuvastatin was effective in lowering LDL-C values in patients with hypercholesterolaemia to the 1998 European target at week 24. However, compliance enhancement tools did not increase the number of patients achieving any European targets for plasma lipids." @default.
• W2187788467 created "2016-06-24" @default.
• W2187788467 creator A5008077016 @default.
• W2187788467 creator A5010793478 @default.
• W2187788467 creator A5048531148 @default.
• W2187788467 creator A5087090678 @default.
• W2187788467 date "2008-07-26" @default.
• W2187788467 modified "2023-09-25" @default.
• W2187788467 title "Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia" @default.
• W2187788467 cites W101424835 @default.
• W2187788467 cites W1845103384 @default.
• W2187788467 cites W1973523240 @default.
• W2187788467 cites W1979111427 @default.
• W2187788467 cites W2004539225 @default.
• W2187788467 cites W2011990461 @default.
• W2187788467 cites W2019707681 @default.
• W2187788467 cites W2044255545 @default.
• W2187788467 cites W2064298819 @default.
• W2187788467 cites W2067504641 @default.
• W2187788467 cites W2069432646 @default.
• W2187788467 cites W2078991136 @default.
• W2187788467 cites W2083210426 @default.
• W2187788467 cites W2088531744 @default.
• W2187788467 cites W2101908189 @default.
• W2187788467 cites W2108634795 @default.
• W2187788467 cites W2114642244 @default.
• W2187788467 cites W2127313704 @default.
• W2187788467 cites W2129750583 @default.
• W2187788467 cites W2135648839 @default.
• W2187788467 cites W2146540041 @default.
• W2187788467 cites W2151628775 @default.
• W2187788467 cites W2153788691 @default.
• W2187788467 cites W2155598961 @default.
• W2187788467 cites W2157027761 @default.
• W2187788467 cites W2164542079 @default.
• W2187788467 cites W2183761985 @default.
• W2187788467 cites W2292757055 @default.
• W2187788467 cites W2322095705 @default.
• W2187788467 cites W2404174322 @default.
• W2187788467 cites W2416472086 @default.
• W2187788467 cites W3127316896 @default.
• W2187788467 cites W3170415215 @default.
• W2187788467 cites W2032525547 @default.
• W2187788467 doi "https://doi.org/10.4414/smw.2008.12120" @default.
• W2187788467 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18654867" @default.
• W2187788467 hasPublicationYear "2008" @default.
• W2187788467 type Work @default.
• W2187788467 sameAs 2187788467 @default.
• W2187788467 citedByCount "5" @default.
• W2187788467 countsByYear W21877884672013 @default.
• W2187788467 countsByYear W21877884672014 @default.
• W2187788467 countsByYear W21877884672019 @default.
• W2187788467 crossrefType "journal-article" @default.
• W2187788467 hasAuthorship W2187788467A5008077016 @default.
• W2187788467 hasAuthorship W2187788467A5010793478 @default.
• W2187788467 hasAuthorship W2187788467A5048531148 @default.
• W2187788467 hasAuthorship W2187788467A5087090678 @default.
• W2187788467 hasBestOaLocation W21877884671 @default.
• W2187788467 hasConcept C126322002 @default.
• W2187788467 hasConcept C15744967 @default.
• W2187788467 hasConcept C2778163477 @default.
• W2187788467 hasConcept C2779519902 @default.
• W2187788467 hasConcept C2780499067 @default.
• W2187788467 hasConcept C2781460075 @default.
• W2187788467 hasConcept C71924100 @default.
• W2187788467 hasConcept C77805123 @default.
• W2187788467 hasConceptScore W2187788467C126322002 @default.
• W2187788467 hasConceptScore W2187788467C15744967 @default.
• W2187788467 hasConceptScore W2187788467C2778163477 @default.
• W2187788467 hasConceptScore W2187788467C2779519902 @default.
• W2187788467 hasConceptScore W2187788467C2780499067 @default.
• W2187788467 hasConceptScore W2187788467C2781460075 @default.
• W2187788467 hasConceptScore W2187788467C71924100 @default.
• W2187788467 hasConceptScore W2187788467C77805123 @default.
• W2187788467 hasLocation W21877884671 @default.
• W2187788467 hasLocation W21877884672 @default.
• W2187788467 hasLocation W21877884673 @default.
• W2187788467 hasLocation W21877884674 @default.
• W2187788467 hasOpenAccess W2187788467 @default.
• W2187788467 hasPrimaryLocation W21877884671 @default.
• W2187788467 hasRelatedWork W1958603961 @default.
• W2187788467 hasRelatedWork W1993598209 @default.
• W2187788467 hasRelatedWork W2009665402 @default.
• W2187788467 hasRelatedWork W2052678998 @default.
• W2187788467 hasRelatedWork W2083210426 @default.
• W2187788467 hasRelatedWork W2127232229 @default.
• W2187788467 hasRelatedWork W2152065670 @default.
• W2187788467 hasRelatedWork W2316863796 @default.
• W2187788467 hasRelatedWork W2885839802 @default.
• W2187788467 hasRelatedWork W4291819813 @default.
• W2187788467 isParatext "false" @default.
• W2187788467 isRetracted "false" @default.
• W2187788467 magId "2187788467" @default.
• W2187788467 workType "article" @default.